Abivax S.A.(ABVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABVX Abivax S.A.

Trading 04-20 12:52:27 EDT

116.58

-3.58

-2.98%

High120.75	Low116.49	Vol392.18K
Open120.16	D1 Closing120.16	Amplitude3.55%
Mkt Cap9.23B	Tradable Cap4.97B	Total Shares79.19M
T/O46.25M	T/O Rate0.92%	Tradable Shares42.66M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ABVX","market":"US","secType":"STK","nameCN":"Abivax S.A.","latestPrice":116.5825,"timestamp":1776703930486,"preClose":120.16,"halted":0,"volume":392181,"delay":0,"changeRate":-0.029772802929427435,"floatShares":42655700,"shares":79185160,"eps":-5.675825,"marketStatus":"Trading","change":-3.5775,"latestTime":"04-20 12:52:27 EDT","open":120.16,"high":120.75,"low":116.49,"amount":46251111.286575004,"amplitude":0.035453,"askPrice":116.71,"askSize":4,"bidPrice":116.55,"bidSize":19,"shortable":3,"etf":0,"ttmEps":-5.675825,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1776715200000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1697774400000,"exchange":"NASDAQ","adjPreClose":120.16,"preHourTrading":{"tag":"盘前","latestPrice":120.24,"preClose":120.16,"latestTime":"09:29 EDT","volume":14630,"amount":1771223.9622,"timestamp":1776691799999,"change":0.08,"changeRate":0.000666,"amplitude":0.02763},"postHourTrading":{"tag":"盘后","latestPrice":121.16,"preClose":120.16,"latestTime":"19:33 EDT","volume":3730,"amount":449087.68,"timestamp":1776468802203,"change":1,"changeRate":0.008322,"amplitude":0.009071},"volumeRatio":0.688047,"impliedVol":1.0435,"impliedVolPercentile":0.7671},"requestUrl":"/m/hq/s/ABVX","defaultTab":"news","newsList":[{"id":"2624354188","title":"Abivax appoints Michael Nesrallah as chief commercial officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2624354188","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624354188?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:21","pubTimestamp":1775074884,"startTime":"0","endTime":"0","summary":"Abivax (ABVX) has appointed Michael Nesrallah as its chief commercial officer, Nesrallah will lead global commercial strategy and launch preparatio...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-appoints-michael-nesrallah-as-chief-commercial-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-appoints-michael-nesrallah-as-chief-commercial-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622638475","title":"Abivax SA Sponsored ADR (ABVX) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2622638475","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622638475?lang=en_us&edition=fundamental","pubTime":"2026-03-28 22:37","pubTimestamp":1774708628,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Abivax SA Sponsored ADR today and set a price target of $170.00. According to TipRan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/abivax-sa-sponsored-adr-abvx-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/abivax-sa-sponsored-adr-abvx-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AAVXF","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622274070","title":"Abivax SA Sponsored ADR (ABVX) Gets a Buy from Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2622274070","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622274070?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:59","pubTimestamp":1774436387,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Yatin Suneja maintained a Buy rating on Abivax SA Sponsored ADR yesterday and set a price target of $175.00. The company’s share...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/abivax-sa-sponsored-adr-abvx-gets-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/abivax-sa-sponsored-adr-abvx-gets-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AAVXF","BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100070762","title":"Stock Track | Abivax Plummets 5.33% Intraday as CEO Downplays Sale Talk and Eyes Capital Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=1100070762","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100070762?lang=en_us&edition=fundamental","pubTime":"2026-03-25 02:04","pubTimestamp":1774375476,"startTime":"0","endTime":"0","summary":"Abivax S.A. (ABVX) shares plummeted 5.33% during intraday trading on Tuesday.The decline follows news that the company's CEO has downplayed recent takeover speculation, indicating the firm is not...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622768092","title":"Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears","url":"https://stock-news.laohu8.com/highlight/detail?id=2622768092","media":"Benzinga_recent_news","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622768092?lang=en_us&edition=fundamental","pubTime":"2026-03-25 01:53","pubTimestamp":1774374780,"startTime":"0","endTime":"0","summary":"Abivax plans fundraising after June trial data as CEO signals no urgency to sell amid takeover speculation and strong stock momentum.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/24/Russian-Syndicate-Targeted-in-Operation-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/24/Russian-Syndicate-Targeted-in-Operation-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/m-a/26/03/51440538/abivax-ceo-downplays-sale-talk-eyes-capital-raise-as-key-trial-data-readout-nears","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/m-a/26/03/51440538/abivax-ceo-downplays-sale-talk-eyes-capital-raise-as-key-trial-data-readout-nears","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU1868836591.USD","LU0158827948.USD","IE0004445239.USD","LU1988902786.USD","LLII","LU1548497426.USD","LU2602419157.SGD","ELIL","LU0882574055.USD","BK4588","IE0005OL40V9.USD","LU0109394709.USD","LU0787776722.HKD","IE00B775H168.HKD","IE00B4JS1V06.HKD","LU2462157665.USD","LU2237438978.USD","LU2750360641.GBP","LU2357305700.SGD","LU2746668461.USD","LU0683600562.USD","LU0097036916.USD","SG9999014906.USD","IE00B4R5TH58.HKD","LU2168564065.EUR","LU1814569148.SGD","LU0823416689.USD","SG9999015986.USD","IE00BK4W5M84.HKD","IE00BKPKM429.USD","SG9999001176.SGD","ABVX","LU2111349929.HKD","LU2468319806.SGD","LU1629891620.HKD","LU0238689110.USD","LU2361045086.USD","LU1232071149.USD","SGXZ57979304.SGD","LU1323610961.USD","LU1267930730.SGD","BK4516","LU2552382132.HKD","IE00BK4W5L77.USD","LU1804176565.USD","LU0823434740.USD","LU2756315318.SGD","LU0823434583.USD","SGXZ31699556.SGD","LU0417517546.SGD","LU2491049909.HKD","IE00BFSS7M15.SGD","LU2746668974.SGD","SG9999018857.SGD","LU0079474960.USD","LU0820561818.USD","LU0122379950.USD","LU1035775433.USD","LU2237443382.USD","LU2750360997.AUD","LLYX","LU2023250330.USD","LU0820562030.AUD","LU1623119135.USD","LU2087625088.SGD","LU2168564149.EUR","LU2324357040.USD","LU2361044949.HKD","LU0708995401.HKD","LU2108987350.USD","LU2417539215.USD","IE00BJJMRX11.SGD","LU2237443622.USD","IE00BJJMRZ35.SGD","LU2461242641.AUD","LU1551013425.SGD","LU2360106947.USD","LU0198837287.USD","LU2471134952.CNY","LU0786609619.USD","LU1551013342.USD","LU0096364046.USD","LU0316494557.USD","LU2265009873.SGD","LU2491050071.SGD","LU2237443978.SGD","LU2491050154.USD","LU0466842654.USD","LLYZ","SG9999015978.USD","LU2237443465.HKD","SGXZ81514606.USD","IE0004445015.USD","BK4581","LU1720051017.SGD","LU2211815571.USD","BK4007","LU0266013472.USD","LU0256863902.USD","BK4585","LU2089283258.USD","LU1291159041.SGD","SG9999018865.SGD","LU0109391861.USD","LU2106854487.HKD","IE0009355771.USD","LU2112291526.USD","IE00BFSS8Q28.SGD","LU0882574139.USD","LU1868837136.USD","SG9999001176.USD","IE00B2B36J28.USD","LU1127390331.HKD","LU1145028129.USD","LU1917777945.USD","GB00BDT5M118.USD","LU1983299246.USD","LU0320765992.SGD","LU2896262040.SGD","LU0225283273.USD","BK4599","IE0001KFT4U8.USD","LU2756315664.SGD","LU0234572021.USD","LU0289739699.SGD","LU0094547139.USD","LU1720051108.HKD","LU0006306889.USD","LU2023251221.USD","LU0889565916.HKD","LU0210536198.USD","BK4533","LU2552382058.USD","LU0432979614.USD","LU0964807845.USD","LU0058720904.USD","LU0689472784.USD","LU2236285917.USD","LU2237443549.SGD","LU0471298694.HKD","LU2361044865.SGD","SGXZ51526630.SGD","LU0353189680.USD","LU1868836914.USD","LU2456880835.USD","BK4534","LU0456855351.SGD","LU1280957306.USD","LU2089284900.SGD","LU1061106388.HKD","LU1868837300.USD","SGXZ99366536.SGD","LU0203201768.USD","LU2213496289.HKD","LU0353189763.USD","LU1064131342.USD","LU0354030438.USD","LU2168564495.EUR","LU0354030511.USD","LU0323591593.USD","IE00B1BXHZ80.USD","IE00BJLML261.HKD","IE00B1XK9C88.USD","LU1712237335.SGD","LU2471134879.HKD","IE00BJT1NW94.SGD","LU1868836757.USD","LU2237443895.HKD","LU2471134796.USD","LU2063271972.USD","SG9999014880.SGD","LU0158827781.USD","LU0820561909.HKD","LU2168563687.JPY","LU0672654240.SGD","LU0256863811.USD","LU0943347566.SGD","LU2028103732.USD","LU1989771016.USD","SG9999014914.USD","LU1093756168.USD","LU1974910355.USD","ELIS","LU0203202063.USD","SG9999013999.USD","IE00BJJMRY28.SGD","LU2168564222.USD","LU0114720955.EUR","SG9999015945.SGD","IE00B7KXQ091.USD","LU0640476718.USD","IE0002141913.USD","IE00BWXC8680.SGD","SG9999017495.SGD","LU0320765059.SGD","LU2264538146.SGD","IE00BN29S564.USD","IE00BFTCPJ56.SGD","LU0106261372.USD","SG9999014898.SGD","LU2552382215.SGD","LU2023250504.SGD","LU0471298777.SGD","LU2089984988.USD","LU1093756325.SGD","LU1366192091.USD","LU2271345857.HKD","LU0385154629.USD","LU1057294990.SGD","LU0061475181.USD","LU2471134523.USD","SG9999015952.SGD","IE00BKDWB100.SGD","LU1069344957.HKD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621060621","title":"Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC), Talphera (TLPH) and Abivax SA Sponsored ADR (ABVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621060621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621060621?lang=en_us&edition=fundamental","pubTime":"2026-03-24 21:10","pubTimestamp":1774357821,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Fennec Pharmaceuticals (FENC), Talphera (TLPH) and A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fennec-pharmaceuticals-fenc-talphera-tlph-and-abivax-sa-sponsored-adr-abvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fennec-pharmaceuticals-fenc-talphera-tlph-and-abivax-sa-sponsored-adr-abvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","HCSG","XBI","TLPH","XLV","BK4139","LU0029874061.USD","FENC","BK4588","BK4007","LABU","LU0128526141.USD","ABVX","BK4581","BK4585","AAVXF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621068237","title":"Abivax price target raised to $148 from $142 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2621068237","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621068237?lang=en_us&edition=fundamental","pubTime":"2026-03-24 17:30","pubTimestamp":1774344612,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Abivax (ABVX) to $148 from $142 and keeps an Overweight rating on the shares. The firm says the “clean” ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-price-target-raised-to-148-from-142-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-price-target-raised-to-148-from-142-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621403219","title":"Abivax SA reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2621403219","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621403219?lang=en_us&edition=fundamental","pubTime":"2026-03-24 11:14","pubTimestamp":1774322092,"startTime":"0","endTime":"0","summary":"Abivax SA reports results for the quarter ended December 31 - Earnings SummaryAbivax SA ABVX.OQ reported a quarterly adjusted loss of 1.14 per share for the quarter ended December 31.  The mean expect","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nL8N40C048:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621084577","title":"Abivax 2025 Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2621084577","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621084577?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:20","pubTimestamp":1774297237,"startTime":"0","endTime":"0","summary":"Abivax  reported full-year 2025 net loss late Monday of 336.1 million euros , widening from a loss of 176.2 million euros a year earlier.As of Dec. 31, the company had cash and cash equivalents of 530.4 million euros, expected to fund operations into Q4 2027.Sofinnova Partners, represented by Kinam Hong, stepped down from the board last week, the company added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621583774","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2621583774","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621583774?lang=en_us&edition=fundamental","pubTime":"2026-03-23 18:00","pubTimestamp":1774260000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVTX","AGX","DOO","EPAC","DPRO","EDAP","CGNT","FENC","IKT","ACHV","HYPD","ABOS","BTGO","CMC","CTAS","BZAI","CNXC","IMDX","AIR","KBH","CELC","BCAX","CNM","EVTL","DEFT","GUTS","ABSI","BRZE","BAK","FBRX","FUL","JBS","KALV","EQ","HSAI","MXCT","CNTA","HUMA","CHWY","ABVX","DERM","BYND","CCL","CNTX","FEMY","IMNN","JEF","CNTB","GOVX","AUTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621793887","title":"LifeSci Capital Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621793887","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621793887?lang=en_us&edition=fundamental","pubTime":"2026-03-21 22:56","pubTimestamp":1774104961,"startTime":"0","endTime":"0","summary":"In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Abivax SA Sponsored ADR, with a price target of $170.00. Ac...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-their-buy-rating-for-abivax-sa-sponsored-adr-abvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-their-buy-rating-for-abivax-sa-sponsored-adr-abvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","AAVXF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620782840","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2620782840","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620782840?lang=en_us&edition=fundamental","pubTime":"2026-03-20 18:00","pubTimestamp":1774000800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC","CTAS","KALV","CNM","HYPD","ABVX","EPAC","KBH","BRZE","AGX","BYND","FEMY","BZAI","CNTX","BAK","HUMA","HSAI","ALMS","IKT","JEF","EVTL","CHWY","EQ","CNTA","ABSI","GUTS","EDAP","BTGO","CNTB","FUFU","AVTX","KRMN","CMC","FBRX","CUK","GOVX","KOD","IMNN","CNXC","JBS","AIR","ACHV","DOO","CGNT","FUL","DERM","CELC","MXCT","BCAX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620783640","title":"Abivax SA  expected to post a loss of €1.28 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2620783640","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620783640?lang=en_us&edition=fundamental","pubTime":"2026-03-20 15:32","pubTimestamp":1773991952,"startTime":"0","endTime":"0","summary":"Abivax SA  expected to post a loss of 1.28 a share - Earnings Preview Abivax SA ABVX.OQ, ABVX.O is expected to  report resultson March 23 for the period ending December 31 2025The Paris Ile-de-france-","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL8N4080DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620311922","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2620311922","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620311922?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:00","pubTimestamp":1773828000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Accenture Plc A                                  2Q      2.85   6:39 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCO","CRIS","DRIO","FDX","DRI","DLO","BABA","CNXC","AIR","BZAI","CNM","BRAG","ELDN","BGSI","AEBI","ARX","CDNL","FLY","GEMI","ALVO","ACN","CAL","CING","FUFU","GIS","AVR","CLLS","CUK","ECOR","FIVE","GANX","MXCT","EQPT","EVTL","BZ","HNRG","CURV","ETON","CCL","DERM","AVAH","CELC","GRWG","GUTS","ABSI","ABVX","FBRX","BIOA","BRZE"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2619462654","title":"European Equities Traded in the US as American Depositary Receipts Higher Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2619462654","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619462654?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:22","pubTimestamp":1773674559,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were rising on Monday morning, up 1.7% to 1,741.84 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by solar energy technology company Turbo Energy  and clinical stage biotechnology company Abivax , which rose 7.5% and 5.7% respectively. They were followed by telecommunications and consumer electronics company Nokia , which added 4.3%.The decliners from continental Europe were led by biotech company Evaxion  and construction engineering company Cadeler , which fell 7.3% and 4% respectively. They were followed by clinical stage biopharmaceutical company DBV Technologies , which was down 0.8%.From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics  and cruise line operator Carnival , which rose 5.9% and 3.8% respectively.The decliners from the UK and Ireland were led by oncology biotech company Akari Therapeutics  and clinical stage biotech company Biode","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVAX","SLN","AKTX","AFG","CDLR","BK4107","BK4007","NOK","BK4096","IE00BMPRXR70.SGD","TURB","BK4020","DBVT","LNOK","BK4547","BK4117","BDRX","BK4142","BK4139","IE00BMPRXN33.USD","ABVX","CUK","BK4129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619457520","title":"Jefferies Initiates Abivax at Buy With $160 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2619457520","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619457520?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:18","pubTimestamp":1773659935,"startTime":"0","endTime":"0","summary":"Abivax SA (ABVX) has an average rating of buy and mean price target of $153.16, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks an","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619145925","title":"U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2619145925","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619145925?lang=en_us&edition=fundamental","pubTime":"2026-03-16 18:00","pubTimestamp":1773655210,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit TherapeuticsMarch 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-liste","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nL4N4040QY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMT","MUD","FITB","MULL","RPAY","DSGN","CVX","XOMO","MU","TALO","AXP","AR","AAL","ADBE","MPC","MUU","RBRK","RCL","VLO","CDRE","ALG","KO","APEI","AA","PSX","S","SCM","APA","ECL","PI","BLDR","KYMR","ABVX","ALNY","AXPG","INSM","BC","INCY","AROC","XOM","XOMX","CRC","COGT","AALG","ADBG","BRBR","PFSI","XOMZ","RVMD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1113096525","title":"Earning Preview: Abivax S.A. this quarter’s revenue is expected to decrease by 29.21%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1113096525","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113096525?lang=en_us&edition=fundamental","pubTime":"2026-03-16 10:20","pubTimestamp":1773627624,"startTime":"0","endTime":"0","summary":"Abstract Abivax S.A. is scheduled to report quarterly results on March 23, 2026 Pre-Market; investors will watch revenue trajectory, loss containment and any pipeline updates, as consensus...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Earning Preview: Abivax S.A. this quarter’s revenue is expected to decrease by 29.21%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619484806","title":"Abivax SA Sponsored ADR (ABVX) Initiated with a Buy at Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2619484806","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619484806?lang=en_us&edition=fundamental","pubTime":"2026-03-16 08:36","pubTimestamp":1773621370,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Faisal Khurshid initiated coverage with a Buy rating on Abivax SA Sponsored ADR yesterday and set a price target of $160.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/abivax-sa-sponsored-adr-abvx-initiated-with-a-buy-at-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/abivax-sa-sponsored-adr-abvx-initiated-with-a-buy-at-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","BK4139","AAVXF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619481471","title":"Abivax initiated with a Buy at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2619481471","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619481471?lang=en_us&edition=fundamental","pubTime":"2026-03-16 08:15","pubTimestamp":1773620114,"startTime":"0","endTime":"0","summary":"Jefferies initiated coverage of Abivax (ABVX) with a Buy rating and $160 price target The firm views the company’s obefazimod as “differentiated” d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abivax.com","stockEarnings":[{"period":"1week","weight":-0.0474},{"period":"1month","weight":-0.0309},{"period":"3month","weight":0.0261},{"period":"6month","weight":0.2958},{"period":"1year","weight":17.775},{"period":"ytd","weight":-0.109}],"compareEarnings":[{"period":"1week","weight":0.0452},{"period":"1month","weight":0.0736},{"period":"3month","weight":0.0267},{"period":"6month","weight":0.0689},{"period":"1year","weight":0.349},{"period":"ytd","weight":0.0414}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.","exchange":"NASDAQ","name":"Abivax S.A.","nameEN":"Abivax S.A.","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Abivax S.A.(ABVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Abivax S.A.(ABVX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Abivax S.A.,ABVX,Abivax S.A.股票,Abivax S.A.股票老虎,Abivax S.A.股票老虎国际,Abivax S.A.行情,Abivax S.A.股票行情,Abivax S.A.股价,Abivax S.A.股市,Abivax S.A.股票价格,Abivax S.A.股票交易,Abivax S.A.股票购买,Abivax S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Abivax S.A.(ABVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Abivax S.A.(ABVX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}